- Development of a Device to Objectively Measure Pain (R43/R44)
(RFA-DA-18-012)
National Institute on Drug Abuse
Application Receipt Date(s): December 5, 2017), by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. - Development of a Device to Objectively Measure Pain (R41/R42)
(RFA-DA-18-013)
National Institute on Drug Abuse
Application Receipt Date(s): December 5, 2017), by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. - Preparing for Hybrid Effectiveness-Implementation Trials for Heart, Lung, Blood, and Sleep Diseases in the Inpatient Setting (U01)
(RFA-HL-18-018)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): October 31, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. - Increasing Use of Cardiac and Pulmonary Rehabilitation in Traditional and Community Settings (R61/R33)
(RFA-HL-18-019)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): October 19, 2017 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Consortium Linking Oncology with Thrombosis (CLOT) (U01)
(RFA-HL-18-021)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): October 23, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date . Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
Advertisements
